Skip to main content
CLB $12.45 +0.48%
CLB logo

CLB · Core Laboratories Inc. /DE/

Track CLB — free
$12.45 +0.06 (+0.48%) At close · Aug 14
Market Cap
$571.26M
Shares
45.88M
All earnings calls

Earnings call · FY2025 Q3

Core Laboratories Inc. /DE/ Q3 FY2025 Earnings Call

Core Laboratories Inc. /DE/ Q3 FY2025 Earnings Call

Concluded Oct 22, 2025
Oct 22, 2025 18 turns
Period
FY2025 Q3
Runtime
Sources
3 artifacts

Executive readout · one minute

Call research workspace

Read the call alongside every captured source. Audio, transcript, slides and SEC filings stay in one workspace.

Sequential revenue and margin improvement 34 Capital return and shareholder value 20 Reservoir Description segment performance 18 International activity outlook and client engagement 17 Production Enhancement segment performance 17 Geopolitical, sanctions and tariff risks 16

Management tone

Positive

Net tone +35 · low hedging

Grounding quotes
  • “Core continued to execute its strategic plan of technology investments targeted to both solve client problems and capitalize on Core's technical and geographic opportunities.”
  • “There is still uncertainty in the demand for these assay services due to ongoing international geopolitical conflicts and evolving sanctions.”
  • “We have never been better operationally or technologically positioned to help our global client base optimize their reservoirs and to address their evolving needs.”
  • “Core's operational leadership continues to position the company for improving client activity levels in the coming quarters and years.”

Research coverage

3 live sources

Switch sources without leaving this page or losing your listening position.

Revenue $134.52M +0.1% YoY
Diluted EPS $0.30 +20% YoY
Net income $14.24M +21.2% YoY

Research materials

Open the source you need; every reader stays inside this workspace.

Quarter detail

How the reported period landed and where the business moved.

Revenue · segments

Operating Segment Reservoir Description$88.22M -0.7% YoY
Operating Segment Production Enhancement$46.30M +1.6% YoY
Corporate And Other$0

Capital returned

Buybacks · derived
$5.01M
Shares repurchased
462,248
Dividend / share
$0.01
Full-screen source Call document